# Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial

> **NCT06626152** · PHASE2 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 50 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Apo-levocarb

## Key facts

- **NCT ID:** NCT06626152
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626152, "Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06626152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*